Supplement to "Financial Health Economics"

In Section 2, we discuss possible specifications of the preferences of the entrepreneurs.  In section 3, we compute the medical innovation premium for different data frequencies (monthly and annually) and different sample periods.  In the appendix, we report the section, "Risk Factors" from the 10-K filings of Apple and Pfizer.

Supplemental Authors: 
Koijen, Ralph - London Business School
Philipson, Tomas J. - London Business School
Uhlig, Harald - University of Chicago

Back